Oxae 50 mikrogram/dosis næsespray, suspension Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

oxae 50 mikrogram/dosis næsespray, suspension

laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Parilo 50 mikrogram/dosis næsespray, suspension Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

parilo 50 mikrogram/dosis næsespray, suspension

laboratoires gerda - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Prausin 50 mikrogram/dosis næsespray, suspension Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

prausin 50 mikrogram/dosis næsespray, suspension

eg labo - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Metmin 50 mikrogram/dosis næsespray, suspension Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

metmin 50 mikrogram/dosis næsespray, suspension

adamed sp. z.o.o. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Rinoter 50 mikrogram/dosis næsespray, suspension Denemarken - Deens - Lægemiddelstyrelsen (Danish Medicines Agency)

rinoter 50 mikrogram/dosis næsespray, suspension

farma group srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis

Atectura Breezhaler Europese Unie - Deens - EMA (European Medicines Agency)

atectura breezhaler

novartis europharm limited  - indacaterol acetate, mometasone furoate - astma - medicin for obstruktiv sygdomme, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.